Sympathetic nerve-derived ATP regulates renal medullary vasa recta diameter via pericyte cells: a role for regulating medullary blood flow? by C. Crawford et al.
ORIGINAL RESEARCH ARTICLE
published: 29 October 2013
doi: 10.3389/fphys.2013.00307
Sympathetic nerve-derived ATP regulates renal medullary
vasa recta diameter via pericyte cells: a role for regulating
medullary blood flow?
C. Crawford†, S. S. P. Wildman*†, M. C. Kelly , T. M. Kennedy-Lydon and C. M. Peppiatt-Wildman*
Urinary System Physiology Unit, Medway School of Pharmacy, The Universities of Kent and Greenwich, Chatham Maritime, Kent, UK
Edited by:
Bellamkonda K. Kishore, University
of Utah Health Sciences, USA
Reviewed by:
Roger Evans, Monash University,
Australia
Volker Vallon, University of California
San Diegio, USA
Tianxin Yang, University of Utah,
USA
*Correspondence:
S. S. P. Wildman and C. M.
Peppiatt-Wildman, Urinary System
Physiology Unit, Medway School of
Pharmacy, The Universities of Kent
and Greenwich at Medway, Anson
Building, Central Avenue, Chatham
Maritime, Chatham, Kent, ME4 4TB,
UK
e-mail: s.s.wildman@kent.ac.uk;
c.m.peppiatt@kent.ac.uk
†Joint first authors.
Pericyte cells are now known to be a novel locus of blood flow control, being able to
regulate capillary diameter via their unique morphology and expression of contractile
proteins. We have previously shown that exogenous ATP causes constriction of vasa
recta via renal pericytes, acting at a variety of membrane bound P2 receptors on
descending vasa recta (DVR), and therefore may be able to regulate medullary blood flow
(MBF). Regulation of MBF is essential for appropriate urine concentration and providing
essential oxygen and nutrients to this region of high, and variable, metabolic demand.
Various sources of endogenous ATP have been proposed, including from epithelial,
endothelial, and red blood cells in response to stimuli such as mechanical stimulation,
local acidosis, hypoxia, and exposure to various hormones. Extensive sympathetic
innervation of the nephron has previously been shown, however the innervation reported
has focused around the proximal and distal tubules, and ascending loop of Henle.
We hypothesize that sympathetic nerves are an additional source of ATP acting at
renal pericytes and therefore regulate MBF. Using a rat live kidney slice model in
combination with video imaging and confocal microscopy techniques we firstly show
sympathetic nerves in close proximity to vasa recta pericytes in both the outer and
inner medulla. Secondly, we demonstrate pharmacological stimulation of sympathetic
nerves in situ (by tyramine) evokes pericyte-mediated vasoconstriction of vasa recta
capillaries; inhibited by the application of the P2 receptor antagonist suramin. Lastly,
tyramine-evoked vasoconstriction of vasa recta by pericytes is significantly less than
ATP-evoked vasoconstriction. Sympathetic innervation may provide an additional level of
functional regulation in the renal medulla that is highly localized. It now needs to be
determined under which physiological/pathophysiological circumstances that sympathetic
innervation of renal pericytes is important.
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INTRODUCTION
Dogma suggests that arterioles and precapillary sphincters are the
key regulatory mechanisms of blood flow at the tissue level, how-
ever it is now becoming widely accepted that an additional locus
of local blood flow regulation exists—that being pericyte cells
found on the capillaries themselves (Peppiatt-Wildman, 2013).
Pericyte cells are smooth muscle-like cells, comprised of a cell
body and long processes, which run along and wrap-around the
capillary, and possess the contractile proteins α-smooth muscle
actin and myosin. Pericytes have the ability to constrict and dilate
capillaries, via their processes, following exposure to a number
of vasoactive agents including adenosine 5′-triphosphate (ATP)
(Peppiatt et al., 2006; Crawford et al., 2012; Peppiatt-Wildman,
2013).
Pericytes have been identified on capillaries in many organs
of the body, including the kidney. Within the kidney, pericytes
are primarily located on descending vasa recta (DVR) capillar-
ies (Park et al., 1997). DVR extend from the renal cortex toward
the outer and then inner medulla, with the highest density of
pericytes being observed in the outer medulla (Park et al., 1997;
Crawford et al., 2012). It has been suggested that renal peri-
cytes play an integral role in regulating renal medullary blood
flow (MBF), which in itself is essential to satisfy the conflicting
demands of preserving the cortico-medullary gradients of NaCl
and urea, while maintaining adequate oxygen and nutrient deliv-
ery, as well as metabolic clearance (Kennedy-Lydon et al., 2013).
As such it has been further proposed that dysregulation and/or
dysfunction of the pericyte cells themselves may account and/or
contribute to a number of renal pathologies (Crawford et al.,
2012; Peppiatt-Wildman, 2013).
Using our live tissue slice model (i.e., where vasa recta and
pericytes are located in situ), we previously demonstrated that
exogenous ATP, a well-documented vasoactive transmitter, causes
constriction of vasa recta via renal pericytes (Crawford et al.,
2011). We further demonstrated that exogenous noradrenaline
(NA) causes constriction of DVR via renal pericytes (Crawford
et al., 2012), and ATP acts via a variety of pericyte-membrane
bound P2 receptors (nee purinoceptors), (Crawford et al., 2011).
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Consequently, this study added to an already substantial wealth
of scientific publications that propose key physiological roles for
extracellular ATP and P2 receptors (i.e., purinergic signaling)
in the kidney; specifically in this case, a key role for purinergic
signaling in regulating renal MBF (Crawford et al., 2011).
Given the increasing interest in renal purinergic signaling it
is perhaps not surprising that various sources of endogenous
extracellular ATP have been proposed, including renal epithe-
lial, endothelial and red blood cells, in response to stimuli such
as: mechanical stimulation (e.g., stretch, increased flow rate, and
osmotic swelling), local acidosis, hypoxia, exposure to various
hormones (e.g., vasopressin and aldosterone), and to a lesser
extent from sympathetic nerve varicosities (Bodin et al., 1991;
Sprague et al., 1996; Schwiebert, 2001; Jans et al., 2002; Burnstock
and Knight, 2004; Praetorius et al., 2005; Wildman et al., 2009).
Extensive sympathetic innervation of the kidney has previ-
ously been shown, however the innervation reported has focused
around the proximal tubules, distal tubules and ascending loop
of Henle (Dibona, 2000). Sympathetic nerves follow the arterial
vasculature from the renal artery to the outer medullary portions
of the descending (and ascending) vasa recta, but have not been
reported in the inner medulla or papilla regions (Barajas et al.,
1992). Electron microscopy has demonstrated that sympathetic
nerve varicosities come into close contact with effector cell mem-
branes (both tubular and vascular cell) in the renal cortex, where
released transmitters presumably act on receptors expressed by
the effector cells. It is likely that a balance between sympathetic
nerves and intra-renal effector cells is essential for optimal renal
function (Dibona, 2005). Both ATP and NA are co-released from
sympathetic nerve varicosities (Burnstock, 1990). Sympathetic
nerve stimulation has been shown to induce the release of ATP
and NA in human cortical kidney slices (Rump et al., 1996).
In vivo studies in rats and rabbits have shown that cortical blood
flow (CBF) and total renal blood flow (RBF) are regulated in
part, by renal sympathetic nerves, whereby electrical stimulation
causes constriction of arteries and arterioles at higher frequencies
(Rudenstam et al., 1995; Leonard et al., 2000).We now know quite
a lot about the effect of sympathetic nerve stimulation on MBF
(Walkowska et al., 2005; Eppel et al., 2006a,b; Johns et al., 2011)
but some important questions remain, for example are vasa recta
pericytes innervated, can neurotransmitter release from nerves
associated with said pericytes induce vasoconstriction, and does
ATP contribute to this vasoconstriction?
Given that renal pericytes are likely key regulators of MBF,
and that purinergic (and noradrenergic) signaling potentially
plays a role in the regulatory process, we hypothesize that sym-
pathetic nerves may be an additional source of ATP acting at
renal pericytes to regulate MBF. In the current study we use our
novel kidney tissue slice model in combination with immuno-
histochemistry to determine the proximity of vasa recta peri-
cytes to sympathetic nerves in the renal medulla. In addition
we investigate the effect of pharmacologically stimulating the
release of transmitter substances (ATP and NA) from sympathetic
nerves on pericyte activity. Identification of a new pathway (i.e.,
sympathetic innervation) for the regulation of renal pericytes
may inform studies seeking to delineate the elusive mechanisms
underlying renal pathology.
METHODS
TISSUE SLICING
Animal experiments were conducted in accordance with United
Kingdom Home Office Scientific Procedures Act (1986). Kidney
tissue slices were obtained as previously described (Crawford
et al., 2012). Adult male Sprague Dawley rats (∼250 g, purchased
from Charles River UK Ltd., Kent, UK) were killed by cervical
dislocation; their kidneys were immediately removed and placed
in ice-cold physiological saline solution (PSS) bubbled with 95%
O2/5% CO2 and prepared for slicing. Prior to slicing, the kid-
neys were de-capsulated and any renal artery remnants removed.
A single kidney was secured on the slicing block of a vibratome
tissue slicer (Leica model VT1200S, LeicaMicrosystems (UK) Ltd,
Milton Keynes, UK), and submerged in a bath of ice cold PSS
bubbled with 95% O2/5% CO2. PSS contained (mM) 100NaCl,
5 KCl, 0.24NaH2PO4, 0.96Na2HPO4, 10Na acetate, 1 CaCl2,
1.2MgSO4, 5 glucose, 25NaHCO3, 5 pyruvate (Sigma-Aldrich
Ltd, Dorset, UK). The pH was adjusted to 7.4 using 10M NaOH.
The outer cortical dome region (∼3mm tissue) of the kidney
was removed to expose the top of the renal medulla and serial
200μm-thick coronal kidney slices (in which there was intact
cortex and medulla) were cut. Slices were collected and main-
tained at room temperature in a holding chamber containing
PSS, and bubbled with 95% O2/5% CO2 to conserve tissue via-
bility. The slices to be used in “live” experiments were maintained
for up to 3 h in the holding chamber, or slices were fixed with
4% paraformaldehyde (PFA, Sigma-Aldrich Ltd, Dorset, UK) and
used for immunohistochemistry.
IMMUNOHISTOCHEMISTRY
For experiments in which pericytes and sympathetic nerves
were co-labeled, fixed kidney tissue slices were incubated
with anti-NG2 (Calbiochem, Merck Millipore, Middlesex, UK)
and anti-tyrosine hydroxylase (anti-TH; Vector Laboratories
Ltd, Peterborough, UK) primary antibodies, respectively. The
anti-NG2-labeled pericytes were probed with a fluorescent
Alexa Fluor 555-conjugated secondary antibody (Invitrogen Life
Technologies, Paisley, UK), as previously described (Crawford
et al., 2012). The tyrosine-hydroxylase signal was amplified
with a biotinylated secondary antibody and probed with a
FITC-conjugated tertiary antibody (Fluorescent Avidin Kit,
Vector Laboratories Ltd, Peterborough, UK). Kidney slices
were mounted using Citiflour (Agar Scientific Ltd., Stanstead,
UK). The medulla of fixed slices was imaged using a Zeiss
LSM 510 laser scanning confocal microscope (Carl Zeiss Ltd.,
Welwyn Garden City, Hertfordshire, UK). FITC-conjugated sec-
ondary antibodies were excited at 488 nm and Alexa Fluor
555-conjugated secondary antibody excited at 543 nm. Emitted
light was collected with the following filters: long-pass 560 nm
(Alexa Fluor 555) and band-pass 505–550 nm (FITC). Pericytes
and sympathetic nerves were imaged in both the inner and
outer medulla. Z-stack images (40× magnification) were also
obtained in order to measure the distance between nerves
and pericytes. At least three z-stacks were obtained in both
inner and outer medulla per slice. The distances between
sympathetic nerves and the nearest pericyte, in both inner
and outer medulla, were measured using Zeiss LSM image
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browser software (Carl Zeiss Ltd., Welwyn Garden City,
Hertfordshire, UK).
FUNCTIONAL EXPERIMENTS AND ANALYSIS
Functional DIC imaging experiments in live tissue, investigating
in situ pericyte-mediated changes in vasa recta diameter, were
performed as previously described (Crawford et al., 2011, 2012).
Live kidney slices were secured in an open-bath chamber using a
purpose-built platinum slice anchor and transferred to the stage
of an upright Olympus microscope (model BX51WI, Olympus
Microscopy, Southend-on-Sea, UK). Kidney slices were continu-
ously superfused (∼2.5ml/min; 1.25ml bath volume) with PSS,
bubbled with 95% O2/5% CO2 and maintained at room tem-
perature. Pericytes on the vasa recta capillaries (vasa recta were
defined as <10μm in diameter) were identified by their previ-
ously established “bump-on-a-log” morphology (Crawford et al.,
2012), and DIC images were captured through an Olympus 60×
water immersion objective (0.9NA). Real-time video images of
changes in vasa recta diameter were collected every second by
an attached Rolera XR Charge Coupled Devise (CCD) camera
and recorded using Image Pro Software (Media Cybernetics Inc.,
Marlow, UK). Kidney slices were superfused with PSS alone for
70 s to establish a baseline vessel diameter at the pericyte and
non-pericyte site. Slices were then exposed to tyramine [1μM;
for ∼150 s, sufficient time to evoke neurotransmitter release
(Glover et al., 1983)], ATP (100μM), suramin (100μM), or com-
binations of the agents, before being subjected to a PSS wash.
Compounds were purchased from Sigma-Aldrich Ltd, Dorset,
UK, and working solutions were prepared in oxygenated PSS.
Time-series analysis of live kidney slice experiments was
carried out using the public domain software ImageJ (NIH,
http://rsb.info.nih.gov.ij), as previously described (Crawford
et al., 2012). For each experiment, both a pericyte site and a non-
pericyte site were identified on a single vasa recta and the diameter
of the vasa recta at both locations was measured every five
frames for the duration of the experiment (1 frame = 1 s). Each
capillary acted as its own control; an average of the first five mea-
surements was taken to represent the resting baseline diameter
value, and expressed as 100%, for both pericyte and non-pericyte
sites. All subsequent diameter measurements were calculated and
expressed as a percentage of the corresponding baseline value
for both pericyte and non-pericyte sites as previously described
(Crawford et al., 2012).
For all experiments, statistical significance was calculated using
Student’s t-test; P < 0.05 (two tailed) was considered significant.
Values are expressed as mean ± SEM; sample size (n) represents
the number of pericytes (1 pericyte and non-pericyte site per
kidney slice). All experiments were performed in at least three dif-
ferent animals. One vasa recta per kidney slice was used to ensure
all vessels were “naïve” prior to exposure to any drug.
RESULTS
SYMPATHETIC INNERVATION OF THE RENAL MEDULLA
Pericytes and sympathetic nerves were labeled in the medulla of
fixed kidney tissue slices using anti-NG2 and tyrosine hydroxy-
lase (TH) antibodies, respectively, as described in the methods
section (Figures 1Ai, Aii). Pericytes were clearly defined by their
FIGURE 1 | Sympathetic nerves in close apposition to pericyte cells in
the renal medulla. In (Ai), confocal image of fixed kidney slices (outer
medulla region) incubated with anti-NG2, and probed with Alexa
555-conjugated secondary antibody (red) to label vasa recta pericytes and
their processes. Pericyte cell bodies are highlighted (arrowheads), and the
capillary wall is outlined (dotted lines). In (Aii), from the same image as in
(Ai), sympathetic nerves were labeled with anti-tyrosine hydroxylase
primary antibody, probed with Alexa 488-conjugated secondary antibody
(green). In (Aiii), an overlay of images (Ai, Aii) shows sympathetic nerves
running along vasa recta capillaries, in close proximity to pericytes. Scale
bar = 10μm. The distance between pericytes and the nearest sympathetic
nerve varicosity was measured from confocal images using image browser
software. In (B), the distance between pericyte and varicosity was
significantly less in the outer medulla region (n = 21) when compared to
the inner medulla (n = 21; ∗P < 0.05).
bump-on-a-log morphology (Figure 1Ai). Sympathetic nerves
were consistently found running through the entire medulla
region [i.e., both the outer (n = 21) and inner medulla (n = 19)].
In all slices analyzed, sympathetic nerves were found, irrespective
of localization in the medulla, to be in close proximity to vasa
recta perciytes (Figure 1Aiii). Confocal z-stack images were used
to follow nerves through the tissue, and the distance from pericyte
www.frontiersin.org October 2013 | Volume 4 | Article 307 | 3
Crawford et al. Purinergic innervation regulates renal pericytes
to the nearest sympathetic nerve varicosity (defined by their
nodule-like appearance) was measured using image browser soft-
ware (see Supplementary Movie 1 for an example z-stack image).
The distance from pericyte to the nearest sympathetic nerve vari-
cosity was significantly less in the outer medulla (1.58 ± 0.35μm,
n = 21) compared to the innermedulla (4.78 ± 1.08μm, n = 19,
∗P < 0.05, Figure 1B). Appropriate, parallel control experiments
were carried out omitting anti-TH, anti-NG2, and/or biotinylated
secondary antibodies, which confirmed an absence of fluorescent
labeling.
EFFECT OF TYROSINE-EVOKED NEUROTRANSMITTER RELEASE ON
VASA RECTA DIAMETER
Tyramine was superfused onto live kidney tissue slices in order
to stimulate the release of sympathetic neurotransmitters (i.e.,
ATP and NA; via two distinct mechanisms; displacement from
the axoplasm and subsequent vesicular release) from varicosi-
ties (Trendelenberg et al., 1987; Kirkpatrick and Burnstock, 1994)
and the ability of tyramine-evoked neurotransmitter release to
alter the diameter of subsurface vasa recta at both pericyte and
non-pericyte sites was measured. Superfusion (∼150 s) of tyra-
mine (1μM) caused a slowly-reversible vasoconstriction of vasa
recta at pericyte sites (Figure 2A). During exposure to tyramine,
vasoconstriction was significantly greater at pericyte sites (3.9 ±
0.9%, n = 7) than at non-pericyte sites (1.4 ± 0.3%, n = 7, ∗P <
0.05, Figure 2B). Maximum tyramine-evoked vasoconstriction
occurred ∼550 s (534 ± 115 s, n = 7) after the cessation of tyra-
mine superfusion (i.e., during tyramine-washout, Figure 2A).
Maximum vasoconstriction, i.e., during tyramine-washout, at the
pericyte site was 11.9 ± 2.5% as compared to 3.0 ± 0.6% at the
non-pericyte site (n = 7, ∗P < 0.05, Figure 2B), and was signifi-
cantly greater than that measured when tyramine was present in
the bath (∗∗P < 0.05, n = 7, Figure 2B). Complete reversibility
(i.e., when vessel diameter returned to baseline) was seen ≥600 s
from the start of tyramine-washout (n = 7). Using Poiseuille’s
law, the maximum tyramine-evoked vasoconstriction of 12%,
equates to a ∼1.7-fold increase in vasa recta resistance and thus
a ∼40% decrease in blood flow (Peppiatt et al., 2006; Crawford
et al., 2012).
Tyramine evokes the co-release of ATP and NA from sym-
pathetic nerve varicosities. To investigate the proportion of
ATP-mediated vasoconstriction vs. NA-mediated vasoconstric-
tion, suramin was superfused onto the tissue slices, for the
entirety of each experiment, in order to antagonize ATP-
activated P2 receptors, including those present on renal peri-
cytes. Superfusion (for ∼150 s) of tyramine (1μM) following
suramin pre-treatment, and in the continued presence of suramin
(100μM), resulted in the maximum tyramine-evoked vasocon-
striction (measured during tyramine-washout) being reduced by
approximately 50% at pericyte sites (∗∗P < 0.05; Figure 2C). The
maximum tryamine-evoked vasoconstriction at pericyte sites,
in the presence of suramin, was reduced to 5.8 ± 1.7%, and
was still significantly greater than the change in vessel diame-
ter recorded at non-pericyte sites (2.1 ± 0.7%, ∗P < 0.05, n = 6;
Figure 2C). Incidentally, in 6 out of 10 experiments suramin
(100μM) alone caused a modest vasoconstriction of vasa recta
FIGURE 2 | Tyramine-evoked changes in vasa recta diameter. Live
kidney slices were superfused with tyramine (1μM). A typical trace from a
single experiment shows changes in vessel diameter over time at a
pericyte (A, black line) and corresponding non-pericyte site (A, gray line).
Mean data in bar graphs in (B), and (C), show a significantly greater change
in vessel diameter at pericyte sites (black bars) compared to non pericyte
sites (gray bars), both during tyramine (1μM) exposure and during the
tyramine-washout period (B, ∗P < 0.05, n = 7). The constriction measured
at pericyte sites was significantly greater during the tyramine washout step
than that measured when tyramine was present in the bath (B, ∗∗P < 0.05,
n = 7). The maximum tyramine-evoked constriction seen at pericyte sites
was significantly inhibited by the presence of suramin (C, 100μM,
∗∗P < 0.05, n = 6).
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at pericyte sites (2–5%). Whilst suramin significantly altered the
maximum tyramine-evoked constriction of vasa recta by per-
icytes, the presence of suramin did not alter the onset time,
time to maximum effect, nor reversibility, of tyramine-evoked
vasoconstriction (data not shown, n = 6).
Extracellular ATP acts at pericytes to cause vasoconstric-
tion of vasa recta (Crawford et al., 2011) and various sources
of endogenous extracellular ATP have been proposed includ-
ing from renal epithelial cells, endothelial cells, red blood cells,
and sympathetic nerve varicosities. To investigate the signifi-
cance/relative contribution of varicosity-derived ATP to ATP-
evoked, pericyte-mediated, vasoconstriction of vasa recta, the
additive effects of tyramine and ATP (100μM), at a concen-
tration previously shown to evoke the greatest constriction of
vasa recta (Crawford et al., 2011), were investigated. Prolonged
superfusion (∼800 s) of tyramine (1μM) caused a constriction
of vasa recta at pericyte sites (Figure 3A) culminating in a max-
imum effect between 400–600 s (n = 5). During exposure to
tyramine, maximum vasoconstriction was significantly greater
at pericyte sites (7.8 ± 3.6%, n = 5) than at non-pericyte sites
FIGURE 3 | The additive effects of ATP and tyramine on
pericyte-mediated changes in vasa recta diameter. Live kidney slices
were superfused with tyramine (1μM) and ATP (100μM); a typical trace
from one of these experiments shows changes in vessel diameter over
time at a pericyte (A, black line) and corresponding non-pericyte site (A,
gray line). Mean data for these experiments show a significantly greater
change in vessel diameter at pericyte sites (black bars) compared with
non-pericyte sites (gray bars) under all experimental conditions (∗P < 0.05,
n = 5). The combined tyramine (1μM) and ATP (100μM)-evoked
constriction at pericyte sites was significantly greater than that observed
during tyramine (1μM) incubation alone (B, ∗∗P < 0.05, n = 5), and the
pericyte-mediated constriction of vasa recta in the presence of exogenous
ATP was significantly greater than that evoked by tyramine alone
(∗∗∗P < 0.05, n > 5).
(1.6 ± 0.3%, n = 5, ∗P < 0.05, Figure 3B). The co-application
of ATP (100μM; for ∼200 s) with tyramine (1μM) during
the “maximum tyramine-evoked vasoconstriction period” caused
a further increase (∗∗P < 0.05, Figure 3B) in the constriction
of vasa recta at pericyte sites (26.5 ± 4.6%) that was signif-
icantly greater than at non-pericyte sites (1.7 ± 0.5%, n = 5,
∗P < 0.05, Figure 3B). The exogenous ATP-evoked vasoconstric-
tion rapidly desensitized in the presence of exogenous ATP
and complete reversibility was seen ≥700 s from the start of
tyramine/exogenous ATP-washout (Figure 3A). Superfusion (for
∼150 s) of ATP (100μM) alone caused a reversible vasocon-
striction of vasa recta at pericyte sites; maximum exogenous
ATP-evoked vasoconstriction at the pericyte site was 19.4 ±
2.8% as compared to 3.3 ± 2.9% at the non-pericyte site (∗P <
0.05, n = 11, Figure 3B). The exogenous application of ATP
(100μM) alone caused a significantly greater constriction than
that observed with tyramine, at pericyte sites (1μM, ∗∗∗P < 0.05,
Figure 3B).
DISCUSSION
The main findings of this investigation, using the live kidney
slice model, revealed sympathetic nerves in both the outer and
inner medulla regions of the kidney, and that pharmacological
stimulation of sympathetic nerves in situ (by tyramine) evokes
pericyte-mediated vasoconstriction of vasa recta capillaries. More
specifically, we present evidence that (i) sympathetic nerve vari-
cosities are in closer apposition to pericytes in the outer medulla,
(ii) tyramine-evoked vasoconstriction of vasa recta by pericytes
is significantly inhibited by the P2 receptor antagonist suramin,
(iii) tyramine-evoked vasoconstriction of vasa recta by pericytes
is significantly less than exogenous ATP-evoked vasoconstriction.
Importantly, these novel findings reveal innervation of renal per-
icytes by sympathetic nerves, primarily in the outer medulla. This
finding being ratified by previous studies, which describe inner-
vation of medullary tubules (Dibona, 2000; Loesch et al., 2009).
Moreover, functionally these findings demonstrate that sympa-
thetic nerve-derived ATP, acting as a cotransmitter, is as effective
as, or more effective than NA, in its ability to regulate vasa recta
diameter, and thus MBF. As such, sympathetic innervation may
provide an additional level of functional regulation in the renal
medulla that is highly localized (see Figure 4).
SYMPATHETIC NERVE VARICOSITIES IN CLOSE APPOSITION TO
PERICYTES IN THE OUTER MEDULLA
The current study identifies, for the first time, TH-labeled, sym-
pathetic varicosities in both the outer and inner medulla regions
of fixed rat kidney tissue (Figure 1). Our novel live kidney slice
model in combination with confocal z-sectional imaging enabled
us to observe the path of sympathetic nerves through the tis-
sue, running in parallel to vasa recta capillaries in the renal
medulla (see Supplementary Movie 1). Furthermore, we demon-
strate that sympathetic nerve varicosities are in close apposition to
pericyte cells on vasa recta (Figure 1). Interestingly, sympathetic
nerve varicosities are in closer apposition to pericytes in the outer
medulla rather than inner medulla (Figure 1B), perhaps support-
ing a less important role for sympathetic innervation of vasa recta
pericytes in the inner medulla where their density is known to be
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FIGURE 4 | Diagram of proposed sympathetic innervation of renal
pericytes in the outer medulla, whereby ATP is a key neurotransmitter,
along with NA, released from sympathetic nerve varicosities. Released
ATP is likely to act via P2 receptors (ionotropic P2X, or metabotropic P2Y)
on pericyte cells to evoke localized vasoconstriction of vasa recta
capillaries. Based on the findings of others (Loesch et al., 2009), it is likely
that epithelial cells of the outer medulla also receive sympathetic
innervation that affect an abundance of P2 receptors (Wildman et al., 2008),
further supporting the phenomenon of pericyte-mediated tubulovascular
crosstalk in the renal medulla (Peppiatt-Wildman, 2013).
significantly less (Crawford et al., 2012). Pericyte cells were found
to be ∼1.5μm from the nearest varicosity in the outer medulla,
as opposed to ∼5μm in the inner medulla. Autonomic nervous
system synaptic clefts, which allows delivery of co-transmitters
to the site of the effector cells, vary in size with clefts size
ranging from 10 nm up to 2μm (Burnstock, 2008). Varicosities
being similar structures, whereby co-transmitters are released “en
passage,” likely affect effector cells in a 2μm proximity. Given
the close proximity (∼1.5μm) of sympathetic nerve varicosities
to pericytes in the outer medulla, it is therefore plausible that
co-transmitters released by apposite sympathetic nerve varicosi-
ties could act at contractile vasa recta pericytes to regulate vasa
recta capillary diameter and thusMBF, as hypothesized. Similarly,
anti-TH antibodies have previously been used to identify sym-
pathetic nerve varicosities in close apposition to proximal tubule
and collecting duct epithelial cells of the rat kidney cortex (Loesch
et al., 2009). Authors propose that sympathetic neurotransmitters
(primarily ATP), released from varicosity vesicles, may regulate
tubule function in the renal cortex through the activation of
a variety and abundance of ATP-activated P2 receptors; shown
to be expressed throughout the nephron by others (Wildman
et al., 2009). In accordance with the functional data describing
a key role for sympathetic nerve-derived ATP in the regulation
of vasa recta diameter via contractile pericytes, we have previ-
ously reported that vasa recta and associated pericytes express
mRNA for P2X1, 3, and 7 and P2Y4 and 6 (Crawford et al.,
2011). Interestingly, in vivo studies in rabbits conclude that P2X
receptors do not contribute to neurally mediated vasoconstriction
(Eppel et al., 2006a,b,c), however this is perhaps not surprising
given that we have previously demonstrated much higher levels
(40-fold) of P2Y (P2Y4 and P2Y6) than P2X receptormRNA in rat
isolated vasa recta, with pericytes in situ (Crawford et al., 2011);
supporting sympathetically-derived ATP acting via P2Y receptors
on pericytes to mediate vasoconstriction of vasa recta.
It is perhaps interesting to note that whilst all capillary net-
works are deemed to have a degree of pericyte coverage, capillaries
in skeletal muscle of the rat (Saltzman et al., 1992), and periph-
eral blood vessels of the mouse (Long and Segal, 2009), are not
innervated; suggesting that not all pericytes receive sympathetic
innervation.
ATP IS A KEY NEUROTRANSMITTER RELEASED FROM SYMPATHETIC
VARICOSITIES
As well as being a substrate for NA synthesis, the ability of
tyramine to evoke sympathetic neurotransmitter release is well
documented (Kirkpatrick and Burnstock, 1994). Notably in our
preparation, the time between application of tyramine and max-
imum dilation of vasa recta by pericytes (∼550 s) is greater than
that seen by the superfusion of a vasoactive agent like NA or ATP
(∼100 s; Crawford et al., 2011, 2012). In our slice preparation
it is likely that tyramine is both responsible for release, synthe-
sis and subsequent release of newly synthesized co-transmitters
(Figure 2A). Various neurotransmitters, most notably NA and
ATP are contained in a single sympathetic nerve varicosity, all of
which are released at one time, the proportion of each released in
the current study was unknown. Pharmacological intervention,
using a specific ATP-activated P2 receptor antagonist, suramin,
allowed an estimation of the proportion of the tyramine-evoked
response attributable to ATP released from sympathetic nerves.
Tyramine-evoked vasoconstriction of vasa recta by pericytes
was significantly inhibited (∼50%) by the P2 receptor antago-
nist suramin (Figure 2C), suggesting a key role for sympathetic
purinergic signaling in the regulation of MBF by renal peri-
cytes. Interestingly, others have shown that the α-adrenoceptor
antagonist prazosin greatly reduces RBF and CBF in response to
renal nerve stimulation, yet MBF was both reduced and increased
(Chapman et al., 1982; Eppel et al., 2004, 2006a,b,c). This may
of course be due to the relative expression of α-adrenoceptors in
the vasculature throughout the kidney, which was not reported by
authors of these studies.
SYMPATHETIC INNERVATION PROVIDES A FINE-TUNING MECHANISM
The current study demonstrates that the vasoconstriction of vasa
recta by pericytes evoked by: (i) superfusion of ATP onto live kid-
ney slices, and (ii) tyramine-stimulated release of co-transmitters,
are additive. The renal medulla contains numerous potential
sources of vasoactive ATP, including from tubular cells, endothe-
lial cells, and red blood cells (Bodin et al., 1991; Sprague et al.,
1996; Schwiebert, 2001; Jans et al., 2002; Praetorius et al., 2005;
Wildman et al., 2009), in addition to that released by sympathetic
nerve varicosities. The additive effects of neuronal co-transmitters
and paracrine-released ATP on the renal vasculature, has pre-
viously been demonstrated to enhance smooth-muscle cell-
mediated vasoconstriction of the glomerular afferent arteriole
(Hultstrom et al., 2007). That tyramine-evoked constriction of
vasa recta by pericytes is significantly less than exogenous ATP-
evoked effects, or indeed maximal exogenous NA-evoked effects
(Crawford et al., 2011, 2012), to our minds suggest that sympa-
thetic innervation fine-tuning of MBF can be achieved. However,
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it is noteworthy that different proportions of co-transmitter are
released in different tissues and the contribution of each co-
transmitter can depend on a number of parameters of stimu-
lation, e.g., that short bursts of electrical stimulation favor ATP
release, and longer bursts favor NA (Burnstock, 2007).
CONCLUSIONS
We hypothesized that sympathetic nerves are an additional source
of ATP to act upon renal pericytes to therefore regulate MBF
(see Figure 4). Here we present evidence to support our hypoth-
esis; however acknowledge that in vivo studies are still required to
provide direct information regarding the control of MBF. What
remains to be determined is under which physiological and/or
pathophysiological circumstances that sympathetic innervation
of renal pericytes, and thereforeMBF, is important. Like others we
assume that coordination exists between sympathetic nerves and
intra-renal effectors such as vessels, tubules and juxtaglomeru-
lar cells [neatly termed tubulovascular crosstalk (Dickhout et al.,
2002; Kennedy-Lydon et al., 2013; Peppiatt-Wildman, 2013), see
Figure 4], and that there are functionally specific subgroups of
renal nerve fibers mediating specific effects on the renal tubular,
vascular or juxtaglomerular granular cells, such as those involved
in RBF response and urinary flow rate response (Dibona et al.,
1996; Dibona, 2000). A better understanding of these neural
sub-populations will determine the significance of renal puriner-
gic innervation and MBF, which is undoubtedly overlooked
in light of renal transplantation (denervated kidney) successes,
and misconception that kidneys have complete intrinsic ability
to regulate blood flow without the need for autonomic input
[despite it being well accepted that control of renal hemodynam-
ics involves both intrinsic (myogenic and TGF components of
autoregulation) and extrinsic mechanisms]. To contextualize the
potential significance of these findings, considering what is now
known about the regulation of MBF: despite the hypoxic environ-
ment of the renal medulla, regulated MBF serves to provide the
vascular and highly metabolic tubular cells with adequate oxy-
gen and nutrients whilst clearing metabolic waste. Imbalances
in MBF regulation are detrimental to the health of the kid-
ney as a whole, with localized ischemia leading to papillary
necrosis and loss of appropriate sodium and water transport in
the loops of Henle. Moreover, it is well established that dys-
regulation of MBF, acute or chronic, can result in significant
pathology. Should sympathetically-derived ATP be involved in
said dysregulation, renal pericytes, and indeed purinergic signal-
ing pathways, may represent a novel a therapeutic target in the
future.
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Supplementary Movie 1 | Z-stack series of images showing co-localization
of pericytes and sympathetic nerves in the outer medulla. Pericytes and
sympathetic nerves were labeled with anti-NG2, and tyrosine hydroxylase
primary antibodies, respectively, and were subsequently probed with
fluorescent Alexa-555 (red) and Alexa-488 (green)-conjugated antibodies,
respectively. The z-stack series images 5.6μm through the tissue slice;
sympathetic nerves can be seen to run in close proximity to pericytes on
vasa recta capillaries. Scale bar = 10μm.
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